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Background: Continuous flow Left Ventricular Assist Devices (LVAD) (i.e. HeartMate (HM)II) are increasingly used over pulsatile flow LVADs (i.e. 
HMI), and create a unique physiology of constant pressure in the aortic root. We compared the frequency of AI development in HMI versus HMII 
recipients.
Methods: All pre- and postoperative echocardiograms of 93 HMI and 79 HMII patients implanted at our center between 2004 and 2009 were 
reviewed.
Results: 84 of 93 HMI and 75 of 79 HMII patients had preoperative echocardiograms. Over a mean observation time of 220 days, 4 HMI (4.7%) 
and 12 HMII patients (16%) developed more than mild AI (HMI: mild/moderate = 3, moderate = 1; HMII: mild/moderate = 7, moderate = 4, 
moderate to severe = 1). Significant AI was present in 1% HMI vs. 3% of HMII patients at 30 days and 4% HMI vs. 13% HMII patients at 100 days 
(p=0.03). None of the 14 HMI destination therapy (DT) pts and 4 of 40 (10%) HMI bridge to transplantation (BTT) patients developed AI, while 3 
of 10 (30%) HMII DT patients and 9 of 42 (21%) HMII BTT patients developed AI. HMII patients who developed AI were older (63.7 vs 53.7 years, 
p=0.028) and had larger aortic root diameter at baseline (3.41 and 3.16 cm, p=0.07) than HMII patients who did not develop AI.
Conclusions: Development of AI is common in HM II recipients. Comprehensive preoperative aortic root assessment 
may identify patients at highest risk who might benefit from surgical aortic valve manipulation at the time of implant.
